Literature DB >> 30959142

Astragalus polysaccharides inhibits cardiomyocyte apoptosis during diabetic cardiomyopathy via the endoplasmic reticulum stress pathway.

Shuqin Sun1, Shuo Yang2, Nina An3, Guimei Wang4, Qiang Xu5, Jia Liu6, Yongjun Mao7.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Traditional Chinese medicine Astragalus membranaceus (Fisch.) Bunge (AM) has been utilized for the treatment of diabetes mellitus and its complications for centuries. Astragalus polysaccharides (APS), the main bioactive ingredient extracted from the root of AM, is prescribed widely in China and has definite cardioprotective effect during diabetic cardiomyopathy (DCM). Endoplasmic reticulum (ER) stress-induced apoptosis played a crucial role in the progression of DCM. However, the regulatory mechanisms of APS on ER stress pathway haven't been comprehensively studied so far. AIM OF THE STUDY: The aim of this study was to identify the effect of APS on cardiomyocyte apoptosis and to investigate the mechanisms for the anti-apoptotic effect of APS during DCM.
MATERIALS AND METHODS: DCM rat model was induced by intraperitoneal streptozotocin (STZ) injection and treated with APS for 16 weeks. Cardiac function, pathological changes and apoptotic cells were assessed by echocardiography, hematoxylin-eosin (HE) staining and TUNEL assay, respectively. Expressions of key molecules in ER stress pathway were detected by Western blot analysis. Cardiomyocytes were exposed to high glucose (HG) and treated with APS for 24 h. Cell viability, apoptosis and protein expressions were assessed by MTT, flow cytometer and Western blot analysis, respectively. Moreover, lentivirus over-expressing (OE) C/EBP homologous protein (CHOP) was employed to further investigate the causative role of ER stress pathway in APS-mediated effect on cardiomyocyte apoptosis.
RESULTS: In vivo, the results demonstrated that APS could improve heart function and attenuate myocardial apoptosis in DCM rat model. Further study demonstrated that APS could down-regulate the protein expressions of activating transcription factor 6 (ATF6) and protein kinase RNA-like ER kinase (PERK) related factors of ER stress pathway. In vitro, APS significantly inhibit HG stimulated H9C2 cell apoptosis and the expressions of ATF6 and PERK related proteins of ER stress pathway. However, after CHOP-OE lentivirus transfection, the protective effects of APS were diminished as increased apoptotic rate and higher expression of CHOP.
CONCLUSIONS: APS could attenuate cardiomyocyte apoptosis via down-regulating the expression of ATF6 and PERK related factors of ER stress pathway in DCM rats and HG-stimulated H9C2 cells.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Keywords:  Apoptosis; Astragalus polysaccharides; Diabetes mellitus; Diabetic cardiomyopathy; ER stress pathway

Mesh:

Substances:

Year:  2019        PMID: 30959142     DOI: 10.1016/j.jep.2019.111857

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  13 in total

1.  Glucose fluctuation promotes cardiomyocyte apoptosis by triggering endoplasmic reticulum (ER) stress signaling pathway in vivo and in vitro.

Authors:  Li-Da Wu; Ying Liu; Feng Li; Jia-Yi Chen; Jie Zhang; Ling-Ling Qian; Ru-Xing Wang
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

2.  Network Pharmacology-Based Identification of the Mechanisms of Shen-Qi Compound Formula in Treating Diabetes Mellitus.

Authors:  Zhipeng Hu; Maoyi Yang; Liangjun Yang; Chunguang Xie; Hong Gao; Xiaoxu Fu; Hongyan Xie; Ya Liu
Journal:  Evid Based Complement Alternat Med       Date:  2020-06-04       Impact factor: 2.629

3.  Jianpiyifei II Granules Suppress Apoptosis of Bronchial Epithelial Cells in Chronic Obstructive Pulmonary Disease via Inhibition of the Reactive Oxygen Species-Endoplasmic Reticulum Stress-Ca2+ Signaling Pathway.

Authors:  Long Fan; Leng Li; Xuhua Yu; Ziyao Liang; Tiantian Cai; Yuanbin Chen; Yinji Xu; Tao Hu; Lei Wu; Lin Lin
Journal:  Front Pharmacol       Date:  2020-04-30       Impact factor: 5.810

4.  Exploring Molecular Mechanism of Huangqi in Treating Heart Failure Using Network Pharmacology.

Authors:  Yan-Gu Tao; Xiu-Fang Huang; Jun-Yan Wang; Meng-Ru Kang; Ling-Jun Wang; Shao-Xiang Xian
Journal:  Evid Based Complement Alternat Med       Date:  2020-04-23       Impact factor: 2.629

5.  Calreticulin expression in human cardiac myocytes induces ER stress-associated apoptosis.

Authors:  Michael W Stoner; Charles F McTiernan; Iain Scott; Janet R Manning
Journal:  Physiol Rep       Date:  2020-04

6.  Efficacy and safety of Shenqi Jiangtang Granules plus oral hypoglycemic agent in patients with type 2 diabetes mellitus: A protocol for systematic review and meta-analysis of 15 RCTs.

Authors:  Tianli Li; Hongzheng Li; Yang Wu; Qian Wu; Guozhen Zhao; Zhaolun Cai; Fenglan Pu; Bo Li
Journal:  Medicine (Baltimore)       Date:  2021-02-05       Impact factor: 1.817

7.  Astragaloside IV Improves the Barrier Damage in Diabetic Glomerular Endothelial Cells Stimulated by High Glucose and High Insulin.

Authors:  Tingting Zhao; Jiaye Tian; Tiancheng Xu; Xi Zhang; Qian Xiang; Jianfeng Xiong; Dingkun Gui; Youhua Xu
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-17       Impact factor: 2.629

8.  Delivery of astragalus polysaccharide by ultrasound microbubbles attenuate doxorubicin-induced cardiomyopathy in rodent animals.

Authors:  Yanjie Liu; Li Chen; Hao Wu; Hebin Zhang
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

9.  Inflammatory Serine Proteases Play a Critical Role in the Early Pathogenesis of Diabetic Cardiomyopathy.

Authors:  Mikhail A Kolpakov; Kunal Sikder; Amrita Sarkar; Shaswati Chaki; Sanket K Shukla; Xinji Guo; Zhao Qi; Carlos Barbery; Abdelkarim Sabri; Khadija Rafiq
Journal:  Cell Physiol Biochem       Date:  2019

10.  Network pharmacology-based identification of miRNA expression of Astragalus membranaceus in the treatment of diabetic nephropathy.

Authors:  Yaji Dai; Mingfei Guo; Lei Jiang; Jiarong Gao
Journal:  Medicine (Baltimore)       Date:  2022-02-04       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.